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Introduction: Polymeric microcontainers featuring sizes around 300µm have recently been proposed as a new 
carrier platform for oral drug delivery. While fabricated with the use of high-throughput fabrication techniques 
(UV photolithography, hot embossing), the freedom for geometrical design proves to be limited. The shape of 
the microcontainers is considered to be an important factor for the performance of the carrier system with 
regards to mucoadhesion and orientation of adhesion. Therefore, the presented research aims at manufacturing 
the microcontainer in advantageous geometries exhibiting better mucoadhesive properties.  
Methods: Computational tools designed for topology optimization of heat conduction gives branching designs 
and we thus use these tools to generate a strong geometric contrast between the top and bottom of the 
microcontainers. The microcontainers are then fabricated with the use of a Digital Micromirror Device (DMD)-
based micro-Stereolithography 3D printing system (30µm voxel size) in the shape of a small chip with seven 
microcontainers (diameter: 1400µm) placed on it. The chip is consequently used for analysis of mucoadhesion, 
carried out using a texture analyzer. This is done by first applying force to push the sample into real porcine 
intestinal tissue and subsequent release, and thereby the instrument measures the force needed for the 
separation of sample and tissue.  
Results: The computational topology optimization of the microcontainers converted the basic microcontainer 
design (Fig.1 A1) into a design possessing “hairy” extrusions pointing out from the microcontainer edge (Fig.1 
A2). The successfully printed samples (Fig.1 B1, B2) were used for the determination of the mucoadhesive 
force employing texture analyzer experiments (Fig.1 C). Consequently, the comparison of the average peak 
force clearly shows a significantly (p = 0.0022) higher value for the optimized “hairy” samples towards the 
non-optimized samples (Fig.1 D).  
Conclusion: The obtained results suggest that the geometrical optimization of microcontainers can lead to an 
improved mucoadhesion and therefore, potentially to a generally improvement of the performance as an oral 
drug delivery system. 
 
Learning Objectives: 
1. Explain why 3D printing was chosen as fabrication method for this work. 
2. Discuss how geometrical optimization of the mini-devices might lead to an overall improvement of 
the performance as a drug carrier system. 
3. Identify the major difference in the design approach of this drug delivery system in comparison to 
others like e.g. nanoparticles, liposomes etc. 
  
 
Figure 1 Experimental determination of mucoadhesive properties of topology optimized and non-optimized 3D printed 
mini-devices (microcontainers) for oral drug delivery. (A1) CAD-drawing of non-optimized sample.  (A2) CAD-drawing 
of topology optimized sample. (B1) Light-microscope image of a single non-optimized microcontainer. (B2) Light-
microscope image of a single topology optimized microcontainer. (C) Typical plot of a force measurement of a topology 
optimized sample using a texture analyzer instrument and porcine intestinal tissue. (D) Comparison of the average peak 
force of non-optimized samples (Control) and topology optimized samples (Structured) (n=3, **: p=0.0022). 
 
